Uncover what drives alcoholic hepatitis, how it’s detected, and why stopping alcohol is vital for better health and recovery.

In April 2025, Vir Biotechnology Inc. announced a phase 1b/2 platform study framework to evaluate the safety and efficacy of ...

An in-depth look at Hepatitis D, why it’s so severe, and how new therapies bring hope for better treatment and prevention.

Chronic hepatitis B (CHB) is currently estimated to affect over 250 million people worldwide, and tenofovir disoproxil fumarate (TDF) is currently the most widely used antiviral agent for CHB ...

While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to ...

The following is a summary of “Chronic hepatitis B virus infection increases the risk of kidney disease while antiviral ...

Hepatitis Australia is calling for a nationwide rollout of universal offer of hepatitis B testing for people aged over 25, ...

Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class ...

Somchai, a Thai native, was 21 years old and faced a double threat to his long-term health and wellbeing. He was living with ...

More Australians die from hepatitis B-related illness each year. Now experts are pushing for universal screening for all adults.

China has made significant progress in reducing mother-to-child transmission of hepatitis B, but further efforts are needed ...

Xie Qing, director of infectious diseases department at Ruijin Hospital, which is affiliated with Shanghai Jiao Tong ...